| Year |
Citation |
Score |
| 2021 |
Machhi J, Yeapuri P, Lu Y, Foster E, Chikhale R, Herskovitz J, Namminga KL, Olson KE, Abdelmoaty MM, Gao J, Quadros RM, Kiyota T, Jingjing L, Kevadiya BD, Wang X, et al. CD4+ effector T cells accelerate Alzheimer's disease in mice. Journal of Neuroinflammation. 18: 272. PMID 34798897 DOI: 10.1186/s12974-021-02308-7 |
0.352 |
|
| 2018 |
Kiyota T, Machhi J, Lu Y, Dyavarshetty B, Nemati M, Zhang G, Lee Mosley R, Gelbard HA, Gendelman HE. URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer's disease. Journal of Neuroinflammation. 15: 137. PMID 29729668 DOI: 10.1186/S12974-018-1172-Y |
0.445 |
|
| 2018 |
Kiyota T, Machhi J, Lu Y, Dyavarshetty B, Nemati M, Yokoyama I, Lee Mosley R, Gendelman HE. Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice. Journal of Neuroimmunology. PMID 29573847 DOI: 10.1016/J.Jneuroim.2018.03.009 |
0.468 |
|
| 2016 |
Embury CM, Dyavarshetty B, Lu Y, Wiederin JL, Ciborowski P, Gendelman HE, Kiyota T. Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer's Disease. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27966067 DOI: 10.1007/S11481-016-9721-6 |
0.408 |
|
| 2016 |
Dong W, Embury CM, Lu Y, Whitmire SM, Dyavarshetty B, Gelbard HA, Gendelman HE, Kiyota T. The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. Journal of Neuroinflammation. 13: 184. PMID 27401058 DOI: 10.1186/S12974-016-0646-Z |
0.42 |
|
| 2015 |
Varnum MM, Kiyota T, Ingraham KL, Ikezu S, Ikezu T. The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease. Neurobiology of Aging. 36: 2995-3007. PMID 26315370 DOI: 10.1016/J.Neurobiolaging.2015.07.027 |
0.759 |
|
| 2015 |
Kiyota T, Zhang G, Morrison CM, Bosch ME, Weir RA, Lu Y, Dong W, Gendelman HE. AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26227349 DOI: 10.1038/Mt.2015.142 |
0.456 |
|
| 2015 |
Kiyota T, Morrison CM, Tu G, Dyavarshetty B, Weir RA, Zhang G, Xiong H, Gendelman HE. Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice. Brain, Behavior, and Immunity. PMID 26112421 DOI: 10.1016/J.Bbi.2015.06.014 |
0.39 |
|
| 2015 |
Kawada H, Blessing K, Kiyota T, Woolman T, Winchester L, Kador PF. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis. Journal of Alzheimer's Disease : Jad. 44: 297-307. PMID 25227315 DOI: 10.3233/Jad-132471 |
0.361 |
|
| 2015 |
Woodbury M, Kiyota T, Ikezu T. Gene delivery and gene therapy for Alzheimer’s disease Neuromethods. 98: 85-120. DOI: 10.1007/978-1-4939-2306-9_4 |
0.639 |
|
| 2013 |
Kiyota T, Gendelman HE, Weir RA, Higgins EE, Zhang G, Jain M. CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease. Neurobiology of Aging. 34: 1060-8. PMID 23040664 DOI: 10.1016/J.Neurobiolaging.2012.08.009 |
0.477 |
|
| 2012 |
Stone DK, Kiyota T, Mosley RL, Gendelman HE. A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease. Neuroscience Letters. 523: 167-73. PMID 22776646 DOI: 10.1016/J.Neulet.2012.06.070 |
0.331 |
|
| 2012 |
Kiyota T, Ingraham KL, Swan RJ, Jacobsen MT, Andrews SJ, Ikezu T. AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APPPS1 mice Gene Therapy. 19: 724-733. PMID 21918553 DOI: 10.1038/Gt.2011.126 |
0.653 |
|
| 2012 |
Lan X, Kiyota T, Hanamsagar R, Huang Y, Andrews S, Peng H, Zheng JC, Swindells S, Carlson GA, Ikezu T. The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 412-23. PMID 21826404 DOI: 10.1007/S11481-011-9304-5 |
0.776 |
|
| 2011 |
Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proceedings of the National Academy of Sciences of the United States of America. 108: E1339-48. PMID 22042871 DOI: 10.1073/Pnas.1102349108 |
0.666 |
|
| 2011 |
Lan X, Xu J, Kiyota T, Peng H, Zheng JC, Ikezu T. HIV-1 reduces Abeta-degrading enzymatic activities in primary human mononuclear phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 186: 6925-32. PMID 21551363 DOI: 10.4049/Jimmunol.1100211 |
0.745 |
|
| 2011 |
Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders (Proceedings of the National Academy of Sciences of the United States of America (2011), 108, (E1339-E1348) DOI: 10.1073/pnas.1102349108) Proceedings of the National Academy of Sciences of the United States of America. 108: 21282. DOI: 10.1073/Pnas.1119280109 |
0.566 |
|
| 2010 |
Flaherty DP, Kiyota T, Dong Y, Ikezu T, Vennerstrom JL. Phenolic bis-styrylbenzenes as β-amyloid binding ligands and free radical scavengers. Journal of Medicinal Chemistry. 53: 7992-9. PMID 21038854 DOI: 10.1021/Jm1006929 |
0.746 |
|
| 2010 |
Kiyota T, Okuyama S, Swan RJ, Jacobsen MT, Gendelman HE, Ikezu T. CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 3093-102. PMID 20371618 DOI: 10.1096/Fj.10-155317 |
0.784 |
|
| 2009 |
Kiyota T, Yamamoto M, Schroder B, Jacobsen MT, Swan RJ, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T. AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 803-809. PMID 28189021 DOI: 10.1038/mt.2009.44 |
0.804 |
|
| 2009 |
Kiyota T, Yamamoto M, Xiong H, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T. CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. Plos One. 4: e6197. PMID 19593388 DOI: 10.1371/Journal.Pone.0006197 |
0.813 |
|
| 2009 |
Kiyota T, Yamamoto M, Schroder B, Jacobsen MT, Swan RJ, Lambert MP, Klein WL, Gendelman HE, Ransohoff RM, Ikezu T. AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 803-9. PMID 19277012 DOI: 10.1038/Mt.2009.44 |
0.817 |
|
| 2008 |
Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T. Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 181: 3877-86. PMID 18768842 DOI: 10.4049/Jimmunol.181.6.3877 |
0.802 |
|
| 2008 |
Yamamoto M, Ramirez SH, Sato S, Kiyota T, Cerny RL, Kaibuchi K, Persidsky Y, Ikezu T. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. The American Journal of Pathology. 172: 521-33. PMID 18187566 DOI: 10.2353/Ajpath.2008.070076 |
0.731 |
|
| 2008 |
Ikezu T, Kiyota T, Yamamoto M, Xu J, Jacobsen MT, Okuyama S. O1-04-08: Therapeutic application of anti-inflammatory cytokines an Abeta-induced cognitive dysfunction Alzheimer's & Dementia. 4: T116-T117. DOI: 10.1016/J.Jalz.2008.05.245 |
0.726 |
|
| 2007 |
Yamamoto M, Kiyota T, Walsh SM, Ikezu T. Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone-marrow-derived macrophages from APP and CCL2 transgenic mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 213-21. PMID 18040846 DOI: 10.1007/S11481-006-9049-8 |
0.809 |
|
| 2007 |
Flaherty DP, Walsh SM, Kiyota T, Dong Y, Ikezu T, Vennerstrom JL. Polyfluorinated bis-styrylbenzene beta-amyloid plaque binding ligands. Journal of Medicinal Chemistry. 50: 4986-92. PMID 17845017 DOI: 10.1021/Jm070085F |
0.774 |
|
| 2007 |
Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. The American Journal of Pathology. 170: 680-92. PMID 17255335 DOI: 10.2353/Ajpath.2007.060378 |
0.77 |
|
| Show low-probability matches. |